Effects of bromocriptine in a patient with crossed nonfluent aphasia: A case report

Objective: Because studies have shown some positive effects of the dopamine rgic agent bromocriptine for improving verbal production in patients with n onfluent aphasia, we examined its effect in a patient with an atypical form of crossed nonfluent aphasia from a right hemisphere lesion. Design: Open-label single-subject experimental ABAB withdrawal design. Patient: A right-handed man who, after a right frontal stroke, developed no nfluent aphasia, emotional aprosodia, and limb apraxia. Intervention: Escalating doses up to 20mg of bromocriptine in 2 separate ph ases. Main Outcome Measures: We measured verbal fluency (words/min in discourse, Thurstone letter fluency), expression of emotional prosody, and gesture pro duction. Results: The patient showed substantial improvement in both verbal fluency measures and no significant improvement in gesture or emotional prosody. Ve rbal fluency improvements continued in withdrawal phases. Conclusions: Our results are less likely caused by practice or spontaneous recovery because we observed little improvement in emotional prosody and ge sture tasks. Verbal fluency improvements during treatment and withdrawal ph ases suggest that the effects of bromocriptine may be long-lasting in its i nfluence on the neural networks subserving verbal initiation.